TCL Archive ASCO: Anastrozole Adds Treatment Option, But Tamoxifen Remains Standard September 13, 2002
TCL Archive Senate Committee Approves Additional $400 Million For NCI, $275 Million For FDA. May 16, 2008
TCL Archive “Clinical research of all kinds in the IRP lacks a rigorous, centralized process for peer review.” July 21, 1995